Best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early sta
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 27, 2021
Neuro42
|
Series A | $6.50M | Biotechnology | — |
Mar 22, 2021
EpimAb Biotherapeutics
|
Series C | $120M | Biopharma | — |
Oct 10, 2018
Berkeley Lights
|
Series E | $95M | Biopharma | — |